Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice

Strong, 2008, Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice, Aging Cell, 7, 641, 10.1111/j.1474-9726.2008.00414.x

Harrison, 2009, Rapamycin fed late in life extends lifespan in genetically heterogeneous mice, Nature, 460, 392, 10.1038/nature08221

Miller, 2007, An aging interventions testing program: study design and interim report, Aging Cell, 6, 565, 10.1111/j.1474-9726.2007.00311.x

Wang, 2004, Statistical methods for testing effects on “maximum lifespan”, Mech Ageing Dev, 125, 629, 10.1016/j.mad.2004.07.003

Promislow, 1999, Below-threshold mortality and its impact on studies in evolutionary ecology, J Evol Biol, 12, 314, 10.1046/j.1420-9101.1999.00037.x

Baur, 2006, Resveratrol improves health and survival of mice on a high-calorie diet, Nature, 444, 337, 10.1038/nature05354

Stanfel, 2009, The TOR pathway comes of age, Biochim Biophys Acta, 1790, 1067, 10.1016/j.bbagen.2009.06.007

Martin, 2005, The expanding TOR signaling network, Curr Opin Cell Biol, 17, 158, 10.1016/j.ceb.2005.02.008

Kapahi, 2004, Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway, Curr Biol, 14, 885, 10.1016/j.cub.2004.03.059

Vellai, 2003, Genetics: influence of TOR kinase on lifespan in C. elegans, Nature, 426, 620, 10.1038/426620a

Jia, 2004, The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span, Development, 131, 3897, 10.1242/dev.01255

Powers, 2006, Extension of chronological life span in yeast by decreased TOR pathway signaling, Genes Dev, 20, 174, 10.1101/gad.1381406

Sharp, 2005, Evidence for down-regulation of phosphoinositide 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR)-dependent translation regulatory signaling pathways in Ames dwarf mice, J Gerontol A Biol Sci Med Sci, 60, 293, 10.1093/gerona/60.3.293

Sun, 2009, Life-span extension in mice by preweaning food restriction and by methionine restriction in middle age, J Gerontol A Biol Sci Med Sci, 64, 711, 10.1093/gerona/glp051

Kaeberlein, 2009, Ageing: A midlife longevity drug?, Nature, 460, 331, 10.1038/460331a

Selman, 2009, Ribosomal protein S6 kinase 1 signaling regulates mammalian life span, Science, 326, 140, 10.1126/science.1177221

Chen, 2009, mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells, Sci Signal, 2, ra75, 10.1126/scisignal.2000559

Lane, 2009, Optimal targeting of the mTORC1 kinase in human cancer, Curr Opin Cell Biol, 21, 219, 10.1016/j.ceb.2009.01.016

Meric-Bernstam, 2009, Targeting the mTOR signaling network for cancer therapy, J Clin Oncol, 27, 2278, 10.1200/JCO.2008.20.0766

Ma, 2009, Novel agents on the horizon for cancer therapy, CA Cancer J Clin, 59, 111, 10.3322/caac.20003

Mahalingam, 2009, Targeting the mTOR pathway using deforolimus in cancer therapy, Future Oncol, 5, 291, 10.2217/fon.09.9

Mita, 2008, Deforolimus (AP23573) a novel mTOR inhibitor in clinical development, Expert Opin Investig Drugs, 17, 1947, 10.1517/13543780802556485

Mita, 2003, The molecular target of rapamycin (mTOR) as a therapeutic target against cancer, Cancer Biol Ther, 2, S169, 10.4161/cbt.365

Warner, 2000, Program for testing biological interventions to promote healthy aging, Mech Ageing Dev, 115, 199, 10.1016/S0047-6374(00)00118-4

Baur, 2006, Therapeutic potential of resveratrol: the in vivo evidence, Nat Rev Drug Discov, 5, 493, 10.1038/nrd2060

Kaeberlein, 1999, The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms, Genes Dev, 13, 2570, 10.1101/gad.13.19.2570

Rogina, 2004, Sir2 mediates longevity in the fly through a pathway related to calorie restriction, Proc Natl Acad Sci U S A, 101, 15998, 10.1073/pnas.0404184101

Tissenbaum, 2001, Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans, Nature, 410, 227, 10.1038/35065638

Pearson, 2008, Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span, Cell Metab, 8, 157, 10.1016/j.cmet.2008.06.011

Wood, 2004, Sirtuin activators mimic caloric restriction and delay ageing in metazoans [erratum appears in Nature. 2004 Sep 2;431(7004):107], Nature, 430, 686, 10.1038/nature02789

Bauer, 2004, An accelerated assay for the identification of lifespan-extending interventions in Drosophila melanogaster, Proc Natl Acad Sci U S A, 101, 12980, 10.1073/pnas.0403493101

Viswanathan, 2005, A role for SIR-2.1 regulation of ER stress response genes in determining C. elegans life span, Dev Cell, 9, 605, 10.1016/j.devcel.2005.09.017

Greer, 2009, Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans, Aging Cell, 8, 113, 10.1111/j.1474-9726.2009.00459.x

Valenzano, 2006, Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate, Curr Biol, 16, 296, 10.1016/j.cub.2005.12.038

Bass, 2007, Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans, Mech Ageing Dev, 128, 546, 10.1016/j.mad.2007.07.007

Borra, 2005, Mechanism of human SIRT1 activation by resveratrol, J Biol Chem, 280, 17187, 10.1074/jbc.M501250200

Kaeberlein, 2005, Substrate-specific activation of sirtuins by resveratrol, J Biol Chem, 280, 17038, 10.1074/jbc.M500655200

Pacholec, 2010, SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1, J Biol Chem, 285, 8340, 10.1074/jbc.M109.088682

Assmus, 2003, HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes, Circ Res, 92, 1049, 10.1161/01.RES.0000070067.64040.7C

Haendeler, 2004, Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells, Circ Res, 94, 768, 10.1161/01.RES.0000121104.05977.F3

Narumiya, 2004, HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells, Cardiovasc Res, 64, 331, 10.1016/j.cardiores.2004.07.011

Kawabata, 2001, Role of cardiac ATP-sensitive K+ channels induced by HMG CoA reductase inhibitor in ischemic rabbit hearts, Hypertens Res, 24, 573, 10.1291/hypres.24.573

Wolfrum, 2003, Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase, J Cardiovasc Pharmacol, 41, 474, 10.1097/00005344-200303000-00017

Verma, 2004, Novel cardioprotective effects of pravastatin in human ventricular cardiomyocytes subjected to hypoxia and reoxygenation: beneficial effects of statins independent of endothelial cells, J Surg Res, 119, 66, 10.1016/j.jss.2003.10.011

Tleyjeh, 2009, Statins for the prevention and treatment of infections: a systematic review and meta-analysis, Arch Intern Med, 169, 1658, 10.1001/archinternmed.2009.286

Murtola, 2010, Prostate cancer and PSA among statin users in the finnish prostate cancer screening trial, Int J Cancer, 127, 1650, 10.1002/ijc.25165

Mondul, 2010, Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004, Cancer Causes Control, 10.1007/s10552-009-9494-9

Caccamo, 2010, Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments, J Biol Chem, 285, 13107, 10.1074/jbc.M110.100420

Spilman, 2010, Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer’s disease, PLoS One, 5, e9979, 10.1371/journal.pone.0009979

Brown-Borg, 1996, Dwarf mice and the ageing process, Nature, 384, 33, 10.1038/384033a0

Weindruch, 1988, The Retardation of Aging and Disease by Dietary Restriction